Admera Health Expands Oncology Test Portfolio with Launch of OncoGxSelect™ at the AMP 2016 Annual Meeting
09 nov. 2016 09h13 HE
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J. and CHARLOTTE, N.C., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Molecular diagnostics company, Admera Health announced the official launch of OncoGxSelect™ while exhibiting at the...
Admera Health Reaches Significant Major Milestone in Achieving New York Department of CLEP Approval for PGxOne™ Plus, a 25 Gene Pharmacogenomics Test
01 nov. 2016 09h13 HE
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Molecular Diagnostics company, Admera Health, (www.admerahealth.com) announced today that it received New York State Clinical Laboratory...
Admera Health Expands its Next Generations Sequencing Based Pharmacogenomics Test with Update to PGxOne™ Plus
21 sept. 2016 09h00 HE
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Sept. 21, 2016 (GLOBE NEWSWIRE) -- Molecular Diagnostics company, Admera Health, (www.admerahealth.com) today announced that its PGxOne™ Plus pharmacogenomics test has been...
Admera Health Launches Molecular Test for Inherited Early Atherosclerosis Diagnosis and Risk
17 mars 2016 07h00 HE
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), a commercial stage New Jersey based Precision Medicine and Digital Health company announced today the...